Reliable AI for Cancer Detection & Diagnosis

diagnostic ai

Paige’s AI applications have been thoughtfully designed, consistently tested, and independently validated to

Better technology is the answer to better patient care. AI is the single most valuable benefit of undergoing digital transformation in pathology, helping to make the challenging or tedious aspects of pathology simpler so pathologists can focus their attention and expertise on what truly matters.

Better technology is the answer to better patient care.

Redefining What Digital Pathology Can Do

Paige’s AI applications are designed to assist pathologists through routine workflows, offering customized solutions to meet the specific needs of each individual user. Powered by the Paige Platform, the only digital pathology solution built for AI, Paige and third-party applications are accessible at every step in the diagnostic process in easy-to-use visualizations, offering enhanced insights and efficiencies, streamlining clinical decision-making from the moment the image is generated until the final report is signed off. 

Redefining What Digital Pathology Can Do

How pathologists are using Paige’s Diagnostic AI

By harnessing the capabilities of Paige’s lab-tested AI applications, pathologists around the world are enhancing their diagnostic confidence, improving workflow efficiencies, and ultimately delivering better patient care. From image analysis and decision support to workflow automation, Paige is being used daily to:  

Prioritize cases or individual slides by identifying those suspicious for cancer 

Quickly identify an area on the slide most suspicious for cancer, including hard-to-find or small cancers 

Automate laborious diagnostic tasks including measurement, quantification, and classification 

Reduce false negative rates and provide quality assurance

Paige’s diagnostic AI applications are independently validated to help pathologists deliver the most confident diagnoses possible. Our ground-breaking approach earned Paige the first and only FDA-approval for an AI in pathology, Paige Prostate Detect.*  

Drive Efficiency Across the Entire Cancer Care Workflow

Intuitive & Unique AI Visualizations 

Paige’s proprietary crosshair feature and TissueMap were thoughtfully designed to be easily utilized by pathologists during diagnosis. Carefully curated alongside the industry’s top pathologists, the AI visualizations highlight suspicious areas, rather than covering them with colored heatmaps that make detection difficult. 

Previous
Next

Trusted Technology Built for Clinical Use

With access to the largest dataset used for AI software development in pathology encompassing millions of slides from over 1,000 global institutions, Paige designs systems that empower laboratories with unparalleled knowledge. Our utilization of cutting-edge training techniques, including multiple instance learning, enables Paige products to work out of the box and generalize across any lab setting without requiring additional tuning. Our solutions exhibit remarkable robustness to pre-analytical variations and staining techniques, ensuring consistent and reliable performance on slides prepared at any lab and across any patient data without the need for on-site calibration. 

Quality and Safety are Top Priority

Continuous testing is key to ensuring AI remains safe and effective for real-world use for patients. Paige’s rigorous approach to building, testing, and adhering to the highest regulatory standards in our AI has resulted in:  

CE-IVDD

& IVDR MARKS

UKCA

MARKS

FDA

Authorizations

ISO

13485:2016 Certification

MDSAP

Certification

View all of Paige's regulatory achievements
"The authorization of this AI-based software can help increase the number of identified prostate biopsy samples with cancerous tissue, which can ultimately save lives."
Office of In Vitro Diagnostics and Radiological Health, FDA Center for Devices and Radiological Health
  • 1 Eloy C, Marques A, Pinto J, et al. Artificial intelligence–assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies. Virchows Arch. 2023. doi: 10.1007/s00428-023-03518-5
  • 3 da Silva LM, Pereira EM, Salles PGO, et al. Independent real-world application of a clinical-grade automated prostate cancer detection system. J Pathol. 2021;254(2):147–158. doi: 10.1002/path.5662
  • 4Raciti P, Sue J, Retamero JA, et al. Clinical Validation of Artificial Intelligence–Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection [published online ahead of print, 2022 Dec 20]. Arch Pathol Lab Med. 2022. doi: 10.5858/arpa.2022-0066-OA
  • *In the United States, Paige Prostate Detect (DEN200080) is approved for clinical use with Philips Ultrafast Scanner.